| abstract |
There has been no device which proposes an administration method of an anticancer agent depending on the type of cancer. An administration method proposing device (100) includes an input unit (101) which receives input of type of cancer of a cancer patient; an administration procedure determination unit (102) which determines an administration order of an FEC (F: 5-fluorouracil, E: epirubicin, C: cyclophosphamide) administration cycle and a docetaxel administration cycle depending on the input type of cancer; and a display unit (103) which displays the administration order of the FEC administration cycle and the docetaxel administration cycle which is the determination result of the administration procedure determination unit (102). |